Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Blackwell Kimberly
Chief Executive Officer at Zentalis Pharmaceuticals. Filing since 25 Oct 2021.
CIK 0001816465
Company
Date
Role
Action
Shares
Amount
Of holding
ZNTL
Zentalis Pharmaceuticals, Inc.
13 Nov 2023
Chief Executive Officer
Bought
5,000
$51.45K
2.0%
ZNTL
Zentalis Pharmaceuticals, Inc.
3 Jan 2022
Director
Sold, plan not stated
1,000
$83.74K
16.7%
ZNTL
Zentalis Pharmaceuticals, Inc.
1 Dec 2021
Director
Sold, plan not stated
1,000
$81.84K
16.7%
ZNTL
Zentalis Pharmaceuticals, Inc.
1 Nov 2021
Director
Sold, plan not stated
1,000
$80.46K
16.7%
ZNTL
Zentalis Pharmaceuticals, Inc.
25 Oct 2021
Director
Sold, plan not stated
1,000
$77.59K
16.7%
5 decisions on file.
